Factor IXa for the treatment of bleeding disorders

Details for Australian Patent Application No. 2005228945 (hide)

Owner Baxter International Inc. Baxter Healthcare S.A.

Inventors Baker, Donald A.; Donovan, Shane

Agent Cullens

Pub. Number AU-B-2005228945

PCT Pub. Number WO2005/094873

Priority 60/554,726 19.03.04 US

Filing date 28 February 2005

Wipo publication date 13 October 2005

Acceptance publication date 30 September 2010

International Classifications

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/094873 Priority application(s): WO2005/094873

30 September 2010 Application Accepted

  Published as AU-B-2005228945

27 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005228950-Azabicyclo-octane inhibitors of IAP

2005228941-Multifunctional telescopic monopolar/bipolar surgical device and method therefor